Treatment for Attention Deficit Hyperactivity Disorder (ADHD)

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Attention Deficit Hyperactivity Disorder (ADHD)
Eligibility
7 - 16
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test if it's possible to study the effects of a supplement using at-home blood and urine samples, as well as online questionnaires.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 7 Secondary · Reporting Duration: week 6

once, at baseline
Acceptability measured by a 'yes' response to their preference of using the Tasso device instead of a lab-based blood draw
Acceptability measured by a 'yes' response to their preference of using the at-home dried urine sample collection method instead of a lab-based urine sample collection method
Feasibility measured by count of participants who provide blood using the Tasso device
Feasibility measured by count of participants who provide the dried urine sample
week 6
Abbreviated Acceptability Rating Profile - 7 questions on a 6-point Likert scale
Acceptability measured by a 'yes' response to their preference of completing online remote study visits instead of in-person study visits
Feasibility measured by count of remaining Sticks
Feasibility of remote study visits measured by count of participants who complete all online remote study visits
Monitor participants for side effects by count of 'yes' if listed symptoms are new or have increased in severity, using the question format from the Pediatric Adverse Events Rating Scale

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

20 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: week 6

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
895 Previous Clinical Trials
6,831,285 Total Patients Enrolled
4 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
485 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Jeanette Johnstone, PhDPrincipal InvestigatorOregon Health and Science University

Eligibility Criteria

Age 7 - 16 · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are medication and supplement free (if supplement ingredient is contained in the Lightning Stick) prior to study initiation.
You are willing to collect blood and urine samples once, at home.